Kembi Therapeutics

Business Services · Australia · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Australia

Website

www.kembi.com.au

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Kembi Therapeutics

Kembi Therapeutics is an Australian-founded clinical-stage biotechnology company that develops plasticity-targeting therapies designed to prevent and reverse treatment resistance in aggressive cancers. The company targets the biological mechanisms of cellular plasticity, which allow tumor cells to shift identity and evade targeted therapies. Its lead small molecule compound, KMB-464 (seviteronel), is currently in a Phase 2 clinical trial for metastatic triple-negative breast cancer. Kembi utilizes a pan-tumour platform to address resistance across multiple solid tumour types, delivering its value through a pipeline of first-in-class oncology therapies that block the cellular processes enabling cancer adaptation.Explore more
Kembi Therapeutics's Social MediaPopular SearchesKembi TherapeuticsKembiSIC Code 87,873NAICS Code 54,541Show more

Kembi Therapeutics Org Chart

PhoneEmail
CC
Australia flag for contact location.
Christine Chaffer

Managing Director

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Kembi Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Click to see if Kembi Therapeutics had a recent Job posting/layoffs

Website visits: Recent activity has been detected on your website

Congratulate Masked Content for being promoted to Masked Content at Kembi Therapeutics

Kembi Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Earning: See what the market has to say on Kembi Therapeutics recently announced quarterly report

Funding: Get notified immidiatlly once Kembi Therapeutics has new funding data

Check out if Kembi Therapeutics is spiking on competitors!

Check if Kembi Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Product Launch: Get notified when Kembi Therapeutics launches new products

Recommended Actions

Find VP level buyers at Kembi Therapeutics

Find 3 more new buyers

Illustration of an envelope

Kembi Therapeutics Tech Stack

A closer look at the technologies used by Kembi Therapeutics

Google Workspace

By

Google
Gmail

By

Google
Apache HTTP Server

By

The Apache Software Foundation
jQuery

By

jQuery
See more technologies

Top Business Services Companies

Top companies in Canada by revenue

I-MED Pharma
Locemia Solutions
Trafa Pharmaceutical Supplies
Edesa Biotech
ANGANY
View Full List

Top companies in New Zealand by revenue

Novo Nordisk Pharmaceuticals
logo for Lilly New Zealand
Lilly New Zealand
Diatranz Otsuka
Glycosyn
Endo Health
View Full List

Top companies in United Kingdom by revenue

Medicom Healthcare
Dechra Veterinary Products
Quantum Pharmaceutical
Miltonia Health Science
AstraZeneca
View Full List
See more top companies

Frequently Asked Questions Regarding Kembi Therapeutics

What is Kembi Therapeutics's official website?
Kembi Therapeutics's official website is www.kembi.com.au What is Kembi Therapeutics's Revenue?
Kembi Therapeutics's revenue is <$5 Million What is Kembi Therapeutics's SIC code?
Kembi Therapeutics's SIC: 87,873 What is Kembi Therapeutics's NAICS code?
Kembi Therapeutics's NAICS: 54,541 How many employees does Kembi Therapeutics have?
Kembi Therapeutics has 11-50 employees What industry does Kembi Therapeutics belong to?
Kembi Therapeutics is in the industry of: Business Services, Research & Development What technology does Kembi Therapeutics use?
Some of the popular technologies that Kembi Therapeutics uses are: Google Workspace, Gmail, Apache HTTP Server, jQuery What does Kembi Therapeutics do?

Kembi Therapeutics is an Australian-founded clinical-stage biotechnology company that develops plasticity-targeting therapies designed to prevent and reverse treatment resistance in aggressive cancers. The company targets the biological mechanisms of cellular plasticity, which allow tumor cells to shift identity and evade targeted therapies. Its le... ad small molecule compound, KMB-464 (seviteronel), is currently in a Phase 2 clinical trial for metastatic triple-negative breast cancer. Kembi utilizes a pan-tumour platform to address resistance across multiple solid tumour types, delivering its value through a pipeline of first-in-class oncology therapies that block the cellular processes enabling cancer adaptation.Read More

 What are Kembi Therapeutics social media links?
Kembi Therapeutics Linkedin page Is Kembi Therapeutics a public company?
Kembi Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Kembi Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search